
Danaher Corporation DHR
$ 230.58
0.1%
Quarterly report 2025-Q1
added 04-22-2025
Danaher Corporation DIO Ratio 2011-2025 | DHR
Annual DIO Ratio Danaher Corporation
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 92.9 | 99.2 | 96.6 | 96.5 | 72.9 | 75 | 79.4 | 82.6 | 82.7 | 78 | 70.6 | 71.1 | 74.8 | 82.2 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 99.2 | 70.6 | 82.5 |
Quarterly DIO Ratio Danaher Corporation
| 2025-Q1 | 2024-Q4 | 2024-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 99.5 | - | - | - | - | 95.3 | 89.3 | - | - | 44.8 | 88.6 | - | - | - | 39.1 | - | - | - | 39.9 | - | - | - | 40.9 | - | 84.4 | 80 | 84.7 | - | 84.5 | 83.8 | 85.2 | - | 103 | 82.5 | 79.5 | - | 73.1 | 71.3 | 73.6 | - | 72.5 | 72.6 | 77.5 | - | 77.4 | 75.3 | 78.8 | - | 71.8 | 94.6 | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 103 | 39.1 | 76.6 |
DIO Ratio of other stocks in the Diagnostics research industry
| Issuer | DIO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
25.4 | - | -6.23 % | $ 30.6 M | ||
|
Accelerate Diagnostics
AXDX
|
198 | - | -61.36 % | $ 2.46 M | ||
|
Burning Rock Biotech Limited
BNR
|
243 | $ 20.5 | -4.92 % | $ 221 M | ||
|
Co-Diagnostics
CODX
|
304 | $ 0.23 | -2.26 % | $ 6.75 M | ||
|
Biocept
BIOC
|
21.9 | - | -13.05 % | $ 7.29 M | ||
|
Chembio Diagnostics
CEMI
|
97.6 | - | 0.22 % | $ 16.8 M | ||
|
Castle Biosciences
CSTL
|
48.7 | $ 39.2 | -0.49 % | $ 1.09 B | ||
|
DarioHealth Corp.
DRIO
|
165 | $ 10.56 | 5.18 % | $ 300 M | ||
|
BioNano Genomics
BNGO
|
245 | $ 1.5 | -1.07 % | $ 1.91 M | ||
|
Oxford Immunotec Global PLC
OXFD
|
210 | - | - | $ 562 M | ||
|
Exact Sciences Corporation
EXAS
|
240 | $ 101.62 | 0.04 % | $ 18.8 B | ||
|
DexCom
DXCM
|
119 | $ 67.79 | 0.33 % | $ 26.2 B | ||
|
Enzo Biochem
ENZ
|
156 | - | -8.98 % | $ 14.8 K | ||
|
Fulgent Genetics
FLGT
|
7.17 | $ 26.61 | -0.41 % | $ 805 M | ||
|
Global Cord Blood Corporation
CO
|
89.7 | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
131 | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
42.1 | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
62.8 | - | 0.12 % | $ 80.1 M | ||
|
DermTech
DMTK
|
33.5 | - | -11.32 % | $ 2.94 M | ||
|
CareDx, Inc
CDNA
|
48.3 | $ 19.02 | -2.36 % | $ 1.02 B | ||
|
Heska Corporation
HSKA
|
137 | - | - | $ 1.31 B | ||
|
HTG Molecular Diagnostics
HTGM
|
116 | - | -20.0 % | $ 1.06 M | ||
|
Guardant Health
GH
|
78.4 | $ 101.62 | -1.32 % | $ 12.5 B | ||
|
Aspira Women's Health
AWH
|
23.1 | - | -6.19 % | $ 10.5 M | ||
|
Myriad Genetics
MYGN
|
35.8 | $ 6.35 | -2.08 % | $ 575 M | ||
|
ENDRA Life Sciences
NDRA
|
405 | $ 4.81 | -5.39 % | $ 2.58 M | ||
|
Neogen Corporation
NEOG
|
147 | $ 7.2 | 0.91 % | $ 1.56 B | ||
|
Illumina
ILMN
|
137 | $ 133.99 | -0.71 % | $ 21.3 B | ||
|
Charles River Laboratories International
CRL
|
35.3 | $ 203.2 | -0.17 % | $ 10.4 B | ||
|
Quest Diagnostics Incorporated
DGX
|
10.4 | $ 175.29 | -0.38 % | $ 19.5 B | ||
|
Koninklijke Philips N.V.
PHG
|
89 | $ 27.25 | 0.53 % | $ 20 B | ||
|
Motus GI Holdings
MOTS
|
3.37 K | - | -34.28 % | $ 263 K | ||
|
Laboratory Corporation of America Holdings
LH
|
18.8 | $ 253.12 | -0.33 % | $ 21.2 B | ||
|
ICON Public Limited Company
ICLR
|
0.213 | $ 183.24 | 0.22 % | $ 15.1 B | ||
|
IDEXX Laboratories
IDXX
|
91.6 | $ 684.16 | -0.63 % | $ 56.4 B | ||
|
Personalis
PSNL
|
12.1 | $ 8.02 | -1.47 % | $ 475 M | ||
|
Lantheus Holdings
LNTH
|
44.2 | $ 66.86 | 0.22 % | $ 4.63 B | ||
|
Quidel Corporation
QDEL
|
133 | $ 29.14 | -0.55 % | $ 1.23 B | ||
|
Mettler-Toledo International
MTD
|
79 | $ 1 415.25 | -0.36 % | $ 30 B | ||
|
Agilent Technologies
A
|
97.1 | $ 138.08 | -0.22 % | $ 42 B |